Evidence map›Paper›PMID 28203693›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2017

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.

J-K Lee, S Louzada, Y An, S Y Kim, S Kim, J Youk, S Park, S H Koo, B Keam, Y K Jeon and 4 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  13. Article
  14. [NUT cancer of nasal cavity and sinuses: a case report and literature review].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

J-K LeeKorea Advanced Institute of Science and Technology, Graduate School of Medical Science and Engineering, Daejeon, South Korea.
S LouzadaMolecular Cytogenetics Core Facility, Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Y AnBiomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
S Y KimDepartment of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, South Korea.
S KimSeoul National University Cancer Research Institute, Seoul, South Korea.
J YoukKorea Advanced Institute of Science and Technology, Graduate School of Medical Science and Engineering, Daejeon, South Korea.
S ParkKorea Advanced Institute of Science and Technology, Graduate School of Medical Science and Engineering, Daejeon, South Korea.
S H KooDepartment of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, South Korea.
B KeamDepartment of Internal Medicine Seoul National University Hospital, Seoul, South Korea.
Y K JeonPathology, Seoul National University Hospital, Seoul, South Korea.
J-L KuSeoul National University Cancer Research Institute, Seoul, South Korea.
F YangMolecular Cytogenetics Core Facility, Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
T M KimSeoul National University Cancer Research Institute, Seoul, South Korea.
Y S JuKorea Advanced Institute of Science and Technology, Graduate School of Medical Science and Engineering, Daejeon, South Korea.
Korea Advanced Institute of Science and Technology · KRChungnam National University · KRSeoul National University · KRSeoul National University Hospital · KRWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare aggressive malignancy often occurring in the tissues of midline anatomical structures. Except for the pathognomonic BRD3/4-NUT rearrangement, the comprehensive landscape of genomic alterations in NMCs has been unexplored. Patients and methods: We investigated three NMC cases, including two newly diagnosed NMC patients in Seoul National University Hospital, and a previously reported cell line (Ty-82). Whole-genome and transcriptome sequencing were carried out for these cases, and findings were validated by multiplex fluorescence in situ hybridization and using individual fluorescence probes. Results: Here, we present the first integrative analysis of whole-genome sequencing, transcriptome sequencing and cytogenetic characterization of NUT midline carcinomas. By whole-genome sequencing, we identified a remarkably similar pattern of highly complex genomic rearrangements (previously denominated as chromoplexy) involving the BRD3/4-NUT oncogenic rearrangements in two newly diagnosed NMC cases. Transcriptome sequencing revealed that these complex rearrangements were transcribed as very simple BRD3/4-NUT fusion transcripts. In Ty-82 cells, we also identified a complex genomic rearrangement involving the BRD4-NUT rearrangement underlying the simple t(15;19) karyotype. Careful inspections of rearrangement breakpoints indicated that these rearrangements were likely attributable to single catastrophic events. Although the NMC genomes had >3000 somatic point mutations, canonical oncogenes or tumor suppressor genes were rarely affected, indicating that they were largely passenger events. Mutational signature analysis showed predominant molecular clock-like signatures in all three cases (accounting for 54%-75% of all base substitutions), suggesting that NMCs may arise from actively proliferating normal cells. Conclusion: Taken together, our findings suggest that a single catastrophic event in proliferating normal cells could be sufficient for neoplastic transformation into NMCs.

Indexed as

AdultBromodomain Containing ProteinsCarcinomaCell Transformation, NeoplasticFemaleGene RearrangementHigh-Throughput Nucleotide SequencingHumansIn Situ Hybridization, FluorescenceMaleNuclear ProteinsOncogene Proteins, FusionRNA-Binding ProteinsTranscription FactorsTranscriptomeBRD3 protein, humanBRD4-NUT fusion oncogene protein, humanBromodomain Containing ProteinsNuclear ProteinsOncogene Proteins, FusionRNA-Binding ProteinsTranscription Factorsbromodomain and extra terminalchromoplexycomplex genomic rearrangementmutational signatureNUT midline carcinoma

Identifiers

PMID28203693
PMCPMC5378225
OpenAlexW2588319976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.